Example of European Journal of Drug Metabolism and Pharmacokinetics format
Recent searches

Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format Example of European Journal of Drug Metabolism and Pharmacokinetics format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

European Journal of Drug Metabolism and Pharmacokinetics — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Pharmacology (medical) #93 of 246 up up by 49 ranks
Pharmacology #139 of 297 up up by 58 ranks
journal-quality-icon Journal quality:
Good
calendar-icon Last 4 years overview: 304 Published Papers | 1233 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 03/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access

SAGE

Quality:  
High
CiteRatio: 6.1
SJR: 1.333
SNIP: 1.061
open access Open Access
recommended Recommended

Oxford University Press

Quality:  
High
CiteRatio: 9.1
SJR: 2.124
SNIP: 1.646
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 6.2
SJR: 1.384
SNIP: 1.38
open access Open Access
recommended Recommended

American Society for Microbiology

Quality:  
High
CiteRatio: 9.1
SJR: 2.07
SNIP: 1.44

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

1.913

28% from 2018

Impact factor for European Journal of Drug Metabolism and Pharmacokinetics from 2016 - 2019
Year Value
2019 1.913
2018 1.497
2017 1.362
2016 1.4
graph view Graph view
table view Table view

4.1

24% from 2019

CiteRatio for European Journal of Drug Metabolism and Pharmacokinetics from 2016 - 2020
Year Value
2020 4.1
2019 3.3
2018 2.9
2017 2.2
2016 1.8
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 28% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 24% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.573

11% from 2019

SJR for European Journal of Drug Metabolism and Pharmacokinetics from 2016 - 2020
Year Value
2020 0.573
2019 0.517
2018 0.488
2017 0.338
2016 0.345
graph view Graph view
table view Table view

0.792

10% from 2019

SNIP for European Journal of Drug Metabolism and Pharmacokinetics from 2016 - 2020
Year Value
2020 0.792
2019 0.72
2018 0.659
2017 0.492
2016 0.537
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 11% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 10% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

European Journal of Drug Metabolism and Pharmacokinetics

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

European Journal of Drug Metabolism and Pharmacokinetics

Approved by publishing and review experts on SciSpace, this template is built as per for European Journal of Drug Metabolism and Pharmacokinetics formatting guidelines as mentioned in Springer author instructions. The current version was created on and has been used by 459 authors to write and format their manuscripts to this journal.

i
Last updated on
03 Jun 2020
i
ISSN
0378-7966
i
Open Access
Hybrid
i
Sherpa RoMEO Archiving Policy
Green faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Citation Type
Author Year
(Blonder et al, 1982)
i
Bibliography Example
Beenakker CWJ (2006) Specular andreev reflection in graphene. Phys Rev Lett 97(6):067,007, URL 10.1103/PhysRevLett.97.067007

Top papers written in this journal

Journal Article DOI: 10.1007/BF03189968
Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. Conference report.

Abstract:

This is a summary report of the conference on Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies. The conference was held from December 3 to 5, 1990 in the Washington, DC area and was sponsored by the American Association of Pharmaceutical Scientists, US Food and Drug Administration, Fe... This is a summary report of the conference on Analytical Methods Validation: Bioavailability, Bioequivalence and Pharmacokinetic Studies. The conference was held from December 3 to 5, 1990 in the Washington, DC area and was sponsored by the American Association of Pharmaceutical Scientists, US Food and Drug Administration, Federation International Pharmaceutique, Health Protection Branch (Canada) and Association of Official Analytical Chemists. The purpose of the report is to represent our assessment of the major agreements and issues discussed at the conference. The report is also intended to provide guiding principles for validation of analytical methods employed in bioavailability, bioequivalence and pharmacokinetic studies in man and animals. The objectives of the conference were: 1. To reach a consensus on what should be required in analytical methods validation and the procedures to establish validation; 2. To determine processes of application of the validation procedures in the bioavailability, bioequivalence and pharmacokinetic studies; 3. To develop a report on analytical methods validation (which may be referred to in developing future formal guidelines). Acceptable standards for documenting and validating analytical methods with regard to processes, parameters or data treatments were discussed because of their importance in assessment of pharmacokinetic, bioavailability and bioequivalence studies. Other topics which were considered essential in the conduct of pharmacokinetic studies or in establishing bioequivalency criteria, including measurement of drug metabolites and stereoselective determinations, were also deliberated. read more read less

Topics:

Bioequivalence (56%)56% related to the paper, Bioavailability (52%)52% related to the paper
530 Citations
Journal Article DOI: 10.1007/S13318-012-0112-Y
Isoflavones: estrogenic activity, biological effect and bioavailability
Daniela Cristina Vitale, Cateno Piazza, Barbara Melilli, Filippo Drago1, Salvatore Salomone1

Abstract:

Isoflavones are phytoestrogens with potent estrogenic activity; genistein, daidzein and glycitein are the most active isoflavones found in soy beans. Phytoestrogens have similarity in structure with the human female hormone 17-β-estradiol, which can bind to both alpha and beta estrogen receptors, and mimic the action of estro... Isoflavones are phytoestrogens with potent estrogenic activity; genistein, daidzein and glycitein are the most active isoflavones found in soy beans. Phytoestrogens have similarity in structure with the human female hormone 17-β-estradiol, which can bind to both alpha and beta estrogen receptors, and mimic the action of estrogens on target organs, thereby exerting many health benefits when used in some hormone-dependent diseases. Numerous clinical studies claim benefits of genistein and daidzein in chemoprevention of breast and prostate cancer, cardiovascular disease and osteoporosis as well as in relieving postmenopausal symptoms. The ability of isoflavones to prevent cancer and other chronic diseases largely depends on pharmacokinetic properties of these compounds, in particular absorption and distribution to the target tissue. The chemical form in which isoflavones occur is important because it influences their bioavailability and, therefore, their biological activity. Glucose-conjugated isoflavones are highly polar, water-soluble compounds. They are hardly absorbed by the intestinal epithelium and have weaker biological activities than the corresponding aglycone. Different microbial families of colon can transform glycosylated isoflavones into aglycones. Clinical studies show important differences between the aglycone and conjugated forms of genistein and daidzein. The evaluation of isoflavone metabolism and bioavailability is crucial to understanding their biological effects. Lipid-based formulations such as drug incorporation into oils, emulsions and self-microemulsifying formulations have been introduced to increase bioavailability. Complexation with cyclodextrin also represent a valid method to improve the physicochemical characteristics of these substances in order to be absorbed and distributed to target tissues. We review and discuss pharmacokinetic issues that critically influence the biological activity of isoflavones. read more read less

Topics:

Daidzein (66%)66% related to the paper, Isoflavones (65%)65% related to the paper, Genistein (65%)65% related to the paper, Glycitein (60%)60% related to the paper, Phytoestrogens (58%)58% related to the paper
330 Citations
Journal Article DOI: 10.1007/BF03190223
Pharmacokinetic studies on IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects
N. Barzaghi1, Francesca Crema1, Giuliana Gatti1, G. Pifferi, Emilio Perucca1

Abstract:

IdB 1016 is a complex of silybin (the main active component of silymarin) and phosphatidylcholine, which in animal models shows greater oral bioavailability and therefore greater pharmacological activity compared with pure silybin and silymarin. In order to assess its pharmacokinetic profile in man, plasma silybin levels were... IdB 1016 is a complex of silybin (the main active component of silymarin) and phosphatidylcholine, which in animal models shows greater oral bioavailability and therefore greater pharmacological activity compared with pure silybin and silymarin. In order to assess its pharmacokinetic profile in man, plasma silybin levels were determined after administration of single oral doses of IdB 1016 and silymarin (equivalent to 360 mg silybin) to 9 healthy volunteers. Although absorption was rapid with both preparations, the bioavailability of IdB 1016 was much greater than that of silymarin, as indicated by higher plasma silybin levels at all sampling times after intake of the complex. Regardless of the preparation used, the terminal half-life was relatively short (generally less than 4 h). In a subsequent study, 9 healthy volunteers received IdB 1016 (120 mg b.i.d., expressed as silybin equivalents) for 8 consecutive days. The plasma silybin level profiles and kinetic parameters on day 1 were similar to those determined on day 8. Most of the silybin present in the systemic circulation was in conjugated form. Less than 3% of the administered dose was accounted for by urinary recovery of free plus conjugated silybin, a significant proportion of the dose probably being excreted in the bile. It is concluded that complexation with phosphatidylcholine in IdB 1016 greatly increases the oral bioavailability of silybin, probably by facilitating its passage across the gastrointestinal mucosa. read more read less

Topics:

Bioavailability (51%)51% related to the paper
210 Citations
Journal Article DOI: 10.1007/BF03188811
Comparative pharmacokinetics of silipide and silymarin in rats.
P. Morazzoni, A. Montalbetti, S. Malandrino, G. Pifferi1

Abstract:

The plasma level profile and the biliary excretion of silybin, the main flavanolignan component of silymarin, were evaluated in rats after single equimolar oral doses (200 mg/kg, expressed as silybin equivalents) of the silybin-phosphatidylcholine complex silipide (laboratory code IdB 1016) and of silymarin. Silybin was assay... The plasma level profile and the biliary excretion of silybin, the main flavanolignan component of silymarin, were evaluated in rats after single equimolar oral doses (200 mg/kg, expressed as silybin equivalents) of the silybin-phosphatidylcholine complex silipide (laboratory code IdB 1016) and of silymarin. Silybin was assayed by using a specific HPLC method which allowed also the determination of other flavanolignans present in the biological fluids after administration of silymarin (i.e. silydianin, silycristin and isosilybin). read more read less
145 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for European Journal of Drug Metabolism and Pharmacokinetics.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write European Journal of Drug Metabolism and Pharmacokinetics in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the European Journal of Drug Metabolism and Pharmacokinetics guidelines and auto format it.

2. Do you follow the European Journal of Drug Metabolism and Pharmacokinetics guidelines?

Yes, the template is compliant with the European Journal of Drug Metabolism and Pharmacokinetics guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in European Journal of Drug Metabolism and Pharmacokinetics?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the European Journal of Drug Metabolism and Pharmacokinetics citation style.

4. Can I use the European Journal of Drug Metabolism and Pharmacokinetics templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for European Journal of Drug Metabolism and Pharmacokinetics.

5. Can I use a manuscript in European Journal of Drug Metabolism and Pharmacokinetics that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper European Journal of Drug Metabolism and Pharmacokinetics that you can download at the end.

6. How long does it usually take you to format my papers in European Journal of Drug Metabolism and Pharmacokinetics?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in European Journal of Drug Metabolism and Pharmacokinetics.

7. Where can I find the template for the European Journal of Drug Metabolism and Pharmacokinetics?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per European Journal of Drug Metabolism and Pharmacokinetics's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the European Journal of Drug Metabolism and Pharmacokinetics's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. European Journal of Drug Metabolism and Pharmacokinetics an online tool or is there a desktop version?

SciSpace's European Journal of Drug Metabolism and Pharmacokinetics is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like European Journal of Drug Metabolism and Pharmacokinetics?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like European Journal of Drug Metabolism and Pharmacokinetics?”

11. What is the output that I would get after using European Journal of Drug Metabolism and Pharmacokinetics?

After writing your paper autoformatting in European Journal of Drug Metabolism and Pharmacokinetics, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is European Journal of Drug Metabolism and Pharmacokinetics's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for European Journal of Drug Metabolism and Pharmacokinetics?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for European Journal of Drug Metabolism and Pharmacokinetics. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In European Journal of Drug Metabolism and Pharmacokinetics?

The 5 most common citation types in order of usage for European Journal of Drug Metabolism and Pharmacokinetics are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the European Journal of Drug Metabolism and Pharmacokinetics?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per European Journal of Drug Metabolism and Pharmacokinetics's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download European Journal of Drug Metabolism and Pharmacokinetics in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in European Journal of Drug Metabolism and Pharmacokinetics Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to European Journal of Drug Metabolism and Pharmacokinetics formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template